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Abstract
Background: Intestinal metaplasia of the bladder is an uncommon glandular proliferation. We examined a large
series of intestinal metaplasia for the clinicopathological features and discuss the significance of this lesion.
Methods: All cases of intestinal metaplasia diagnosed in our institution between 1990 and 2014 were retrospectively
reviewed. Patients with a history of urothelial carcinoma or concurrent adenocarcinoma were excluded. Patient
characteristics, pathological features, and follow-up outcomes were obtained.
Results: We identified 89 patients with intestinal metaplasia during this period. Sixty seven were men and 22 were
women. Mean age at diagnosis was 57 years (range 23–81). Common presenting complaints included haematuria
(73 cases), mucosuria (13 cases), and irritative voiding symptoms (seven cases). The majority of intestinal metaplasias
located on or near the trigone (67 cases). Eighty-two patients underwent transurethral resection of their lesions. Partial
cystectomy was performed in the remaining seven patients. The mean follow-up of 78 patients was 105 months
(range 6–255). One case of bladder adenocarcinoma was indentified 6 months later. The initial histologic findings
had revealed intestinal metaplasia with severe dysplasia. Four patients presented recurrence during the follow-up,
and this occurred 9, 13, 17 and 24 months after the surgery.
Conclusions: Although intestinal metaplasia can be treated effectively by transurethral resection in most cases,
its potential malignancy need to be taken into consideration after the evidence of recurrences and its association
with bladder adenocarcinoma. Therefore, it is necessary to perform close surveillance following the surgery, particularly
in patients with dysplastic changes.
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Background
Intestinal metaplasia (IM) of the bladder, characterized
by the presence of intestinal type epithelium in the bladder,
are glandular proliferation that most frequently occur on
the bladder trigone [1, 2]. This condition affects men much
more commonly than women with an overall estimated in-
cidence of 0.1 to 0.9 % [3, 4]. Most cases of IM are diag-
nosed in the fifth to sixth decades of life and they are
thought to be acquired secondary to persistent irritation
and inflammation [1, 5]. Patients have been classically con-
sidered to present with hematuria, lower urinary tract
symptoms and mucosuria, although many patients instead
present with nonspecific urinary complaints. Despite an
improved clinical understanding of these uncommon le-
sions the pathogenesis remains unclear. Proposed etiolo-
gies of IM are congenital and acquired causes, including
bladder extrophy, long-term catheterization, bladder calculi
and neurogenic bladder [1].
The presence of IM as a precursor of adenocarcinoma,
a type of bladder cancer with poor prognosis [6], has
long been debated. In 1958, Shaw et al. published the
first report implicating IM in the development of adeno-
carcinoma of the bladder [7]. After this research, sporadic
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case reports have associated IM with bladder adenocarcin-
oma, prompting consideration of IM as a preneoplastic
condition [4, 8, 9]. However, the premalignant nature of
IM has been questioned by the following investigators.
After reviewing 53 cases, Corica et al. concluded that IM
did not seem to be a risk factor for bladder cancer [10],
and frequent and long-term follow up was not advocated
if a concurrent diagnosis of malignancy was excluded [11].
Such published results have brought conflicting informa-
tion to the practicing urologist.
To further address this topic, we analyzed the clinico-
pathological characteristics of 89 cases of IM in our in-
stitution and to determine the long-term outcomes in
patients with this lesion.
Methods
This study was approved by the institutional review
board of Rui jin Lu Wan Branch, School of Medicine,
Shanghai Jiaotong University. From the bladder tumor
database of the Department of Urology, Rui Jin Hospital
Lu Wan Branch, all consecutive patients with a diagnosis
of bladder IM between 1990 and 2014 were identified.
Bladder IM was defined as the presence of columnar-
lined epithelium in the bladder mucosa (Fig. 1) [1]. ICD-
10 Codes was used in search analysis [12]. Codes that
were used for identification of our patient cohort were
(1) ‘Malignant neoplasm of bladder’ (C67), (2) ‘Benign
neoplasm of Urinary bladder’ (D30.3), (3) ‘Neoplasm of un-
certain or unknown behaviour of urinary organs’ (D41), (4)
‘Other cystitis’ (N30.8), (5) ‘Cystitis, unspecified’ (N30.9),
(6) ‘Other specified disorders of bladder’ (N32.8), and (7)
‘Bladder disorder, unspecified’ (N32.9). We then manually
reviewed all the summary text of pathology reports that
meet the criteria, and examined whether the presence of
IM or columnar lined bladder was mentioned.
Patients with a baseline diagnosis of bladder adenocarcin-
oma in IM were excluded, as were patients with other
urothelial malignancy, registered prior to, or simultaneously
with, the initial diagnosis of IM. The clinical features,
including age, sex, presenting symptoms, cystoscopic
findings, and follow-up status, were obtained from the
medical records and pathology reports.
The follow-up period was defined as the time between
the date of the first cystoscopy with biopsy at which the
diagnosis of bladder IM was made and the date of the
last surveillance cystoscopy. No mandatory surveillance
protocol was followed during the study period, but the
practice in our unit was to perform cystoscopy at an
interval of 3 months during the first year after the sur-
gery followed by yearly cystoscopy.
In all patients included for this study, histological
slides (hematoxylin and eosin staining) were retrieved
and microscopically reviewed by two pathologists. While
reviewing the histological slides, the pathologists were
unaware of the follow-up data.
Results
Among 27,424 patients registered in our bladder tumor
database, we identified 98 patients diagnosis with IM
between 1990 and 2014, resulting in an incidence of
0.26 % in bladder tumor population. A total of 9 patients
were excluded from the analysis because they had concur-
rent carcinoma at baseline. This left 89 patients for ana-
lysis, who were followed up to 21 years. Of this cohort, 67
(75 %) were men and 22 (25 %) were women, with a mean
age of 57 years. The peak incidence of diagnosis was in
the fifth and sixth decades of life. The clinicopathological
characteristics of the patients included are summarized in
Table 1.
The most common presenting complaint was gross or
microscopic haematuria, seen in 73 cases (82 %), followed
by irritative voiding symptoms (13 cases) and mucosuria
(seven cases). Other presenting symptoms included dysuria
Fig. 1 Intestinal metaplasia of the bladder (a) The low magnification
(× 40) demonstrates numerous orderly distribution of intestinal-like
glands in the bladder lamina propria (b) On a higher magnification
(× 100), the glands are lined by tall columnar epithelial cells without
evidence of cytological dysplasia and mitosis
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(two cases), acute urinary retention (three cases), and
suprapubic pain (two cases). Eleven patients had more than
one of these symptoms. The presenting symptoms of the
remaining two patients were not available.
Of the 89 patients, 64 (71 %) had associated with con-
ditions predisposing to the stasis of urine or exposure
to chronic irritants such as bladder outlet obstruction
(12 cases), chronic urinary tract infections (UTI) (29
cases), bladder stones (15 cases), and neurogenic blad-
der (eight cases).
The majority of IMs were located on or near the trigone
(67 cases or 75 %), and the remaining lesions were found
on the dome (two cases), posterior wall (eight cases), and
lateral wall (12 cases, 5 on the left and 7 on the right).
Cystoscopically, most lesions were described as flat and
polypoid masses or papillary lesions with gelatinous sur-
faces. In 24 cases, multifocal lesions were noted. Eighty-
two patients underwent transurethral resection (TUR) of
their lesions. Partial cystectomy was performed in the
remaining seven patients including two patients with
transplantation of ureter.
Cystoscopic follow-up was conducted in 78 patients
(88 %). Five patients had only clinical follow-up, and 6
patients had no additional follow-up in our hospital. The
mean period of follow-up was 105 months (range from
6 to 255 months). At review, 36 patients (40 %) had fol-
low-up for more 10 years. Four patients died of unrelated
diseases during the follow-up period (one of gastric can-
cer, one of pneumonia, one of myocardial infarction, and
one of brain hemorrhage).
Of the 78 patients, four patients (5 %) developed re-
current IM, and this occurred 9, 13, 17 and 24 months
after resection of the initial lesion, respectively (Table 2).
In the first case IM developed in two places 9 months
after TUR, and IM recurred in two places 1 year 3 months
after the surgery. In this example IM recurred two times
thereafter and the patient currently undergoes follow-up
observation. Similar to the first case, in the second case
IM recurred 2 times on the trigone after the surgery.
However, this patient refused to take further re-TUR. In
the third case TUR was performed due to the develop-
ment of IM on the left lateral wall, and IM recurred near
the posterior wall 1 year 5 months after surgery. At this
time, 7 years 2 months after the initial recurrence, this
case remains free from further recurrence. In the forth
case TUR was performed for the development of IM on
the trigone, and IM developed laterally in the right ur-
eteral orifice 2 years later. Unfortunately, IM recurred
9 months later and the patient required re-TUR.
Of note, one patient (1 %) developed subsequent bladder
adenocarcinoma. The patient was a 62-year-old male. He
had presented with macroscopic hematuria, and his lesion
was extensive but mainly located on the trigone. Although
the immediate repeat cystoscopy after TUR was normal,
tumor had developed on the trigone 6 months later.
Histologic review of the originally diagnosed IM disclosed
glandular structures lined by dysplastic columnar cells.
Discussion
Although IM are reported to occur in 0.1 to 0.9 % of the
bladder population, the true incidence is difficult to deter-
mine due to the vague, nonspecific symptoms often associ-
ated with this condition [3, 4]. In this study, we studied 89
patients from 27,424 bladder tumor patients with long-
term follow-up (mean 105 months) after the initial diagno-
sis of IM. To the best our knowledge, this represents the
largest series of IM cases described in a single institution.
In the current series most patients reported symptoms of
haematuria, irritative voiding symptoms and mucosuria in




















Posterior wall 8 (9)




Transurethral resection 82 (92)
Partial cystectomy 7 (8)
Total case(s) of bladder adenocarcinoma 1 (1)
Total case(s) of recurrent intestinal metaplasia 4 (4)
Died of unrelated disease 4 (4)
Died of disease 0 (0)
Abbreviation: LUTS lower urinary tract symptoms, AUR acute urinary retention,
N.A not available
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the fifth to sixth decade of life, which is comparable to that
in prior studies [10, 11]. However, the frequent finding of
gross or microscopic haematuria in 82 % of our patients is
much higher than the rates previously reported in patients
with IM [10].
Although the etiology of IM is not well characterized,
many cases are thought to represent an acquired condi-
tion that occur secondary to long-standing injurious
stimulus [1, 5]. More than half of the patients in our
study had associated conditions predisposing to the sta-
sis of urine or exposure to chronic irritants. Persistent
inflammation of the bladder has been proposed to lead
to adaptation and subsequently transformation of the
urothelium, resulting in the development of glandular
metaplasia [13]. Of the patients in our series 33 % had a
history of chronic UTI, suggesting a possible association
between this finding and an IM in a large proportion.
Grossly, IM can be found anywhere in the bladder but
usually arises from the trigone [2]. In our cases, 75 % of
the IM developed on or near the triangle region, which
is almost consistent with the reports of previous investi-
gators [2]. It is important to note that over one-fourth of
the cases are multifocal, highlighting the entire urothe-
lium needs to be evaluated if a lesion is found.
In theory, the urothelium may return to a normal pat-
tern of differentiation, if the stimulus that caused metapla-
sia is removed or ceased. However, patients often require
surgical intervention due to ongoing clinical symptoms or
concern about dysplastic changes. Because IM has no ten-
dency toward infiltration, and under most circumstances
is superficial [1], nearly all cases in our series were treated
by TUR. However, difficulty in differentiating extensive
IM from adenocarcinoma and occasional coexistence of
IM and carcinoma make cystectomy unavoidable in some
cases. In our cases, seven patients underwent partial
cystectomy to remove the lesions.
The significance of IM of the bladder has been the
subject of numerous debates [1, 5, 13–15]. On the one
hand, numerous of molecular changes have been demon-
strated to be present in the metaplastic changes which in-
dicate that IM may constitute a putative precursor lesion
of adenocarcinoma. By applying the fluorescent in situ
hybridization, Morton et al. provided evidence of signifi-
cant telomere shortening in IM compared with telomere
length in adjacent normal urothelial cells. In addition,
chromosomal abnormalities associated with urothelial
carcinoma were shown to be present in a subset of IM.
The authors concluded that these findings suggest a
premalignant potential of IM [16]. Bryan et al. investi-
gated the role of tumor necrosis factor-alpha and the
adherens junction component beta-catenin in IM, and
found nuclear localization of the latter in IM. Since nu-
clear localization of beta-catenin is also seen in the Barrett
metaplasia of the esophagus, which is a preneoplastic con-
dition [17], the authors concluded that bladder IM may
have the same potential to progress to malignancy [18].
On the other hand, to date only six cases of carcinoma
arising in IM have been reported [4, 7–9, 11, 19]. It is
noteworthy that the malignancies in the IM appear not to
be unique, but one of the standard bladder cancers, ie
adenocarcinoma or transitional cell carcinoma, with the
majority of tumors reported being adenocarcinomas.
However, many documented cases were derived from case
reports and have been criticized to have a history of a
prior or concurrent carcinoma. Furthermore, in a clinical
investigation of 53 patients with IM, Corica et al. found
that none of the patients developed bladder carcinoma
after a median follow-up of 13 years. The authors con-
cluded that IM is not a strong risk factor for bladder car-
cinoma [10]. Smith et al. studied 12 cases of IM and
found that only one patient developed an urothelial car-
cinoma 3 months after resection of an IM; they concluded
that IM does not seem to increase the future risk of blad-
der malignancy and surveillance cystoscopy is not recom-
mended in such patients [11].
In our study we identified carcinoma arising within
1 % of IM and in this case in our series it represented
adenocarcinoma. The result is in contrast to the findings
in previous studies [10, 11]. Several explanations may ac-
count for this discrepancy. First, our cohort includes the
largest number of IM patients to date with long-term
follow-up. This obviously differs from previous small
study with relatively short follow-up, which may not
have adequate power to capture the incidence of events
[11]. Second, in Corica et al. study, most of recruited
patients were children rather than adults in our series
[10]. Metaplastic cells in children with extrophy might
occur at early stage in the replicative cycle and require
Table 2 Clinical details of the four patients that subsequently developed recurrence following the surgery
Pat. No. Gender Age at surgery, yr Onset Site Recurrence Site Interval Before Recurrence Outcome




9 months Recur 15 months later
2 Male 73 Bladder trigone Bladder trigone 13 months Recur 11 months later
3 Male 64 Left lateral wall Posterior wall 17 months Remains free from
further recurrence
4 Male 62 Bladder trigone Laterally in the right
ureteral orifice
24 months Recur 9 months later
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decades to progress to carcinoma [20]. Third, all patients
with extrophy have been underwent surgery to recon-
struct the bladder. It is reasonable to consider that repair
of the extrophy likely removed the stimulus and delay or
reverse the process of carcinogenesis [10].
Although we could not rule out the possibility that de-
velopment within 6 months of a carcinoma in our study
was because an overlook at the time of diagnosis, this
single case highlights several important clinical features. Ex-
tensive lesion was present in the initial cystoscopic findings
but, more importantly, the histologic examination indicated
severe dysplastic changes. Recently, Gordetsky et al. re-
ported the histologic details and follow-up of patients
with dysplasia. With a total of 20 cases included, the
authors concluded that dysplastic changes are signifi-
cantly associated with concurrent adenocarcinoma and
suggested that patients with IM exhibiting this feature
should undergo close follow-up [19].
This might raise the question of whether the pres-
ence of dysplasia is an indicator for the development of
subsequent adenocarcinoma. The metaplasia-dysplasia-
adenocarcinoma sequence is a widely recognized event in
several epithelial tissues including esophagus and gastric
[17, 21]. In supporting this sequence in bladder IM,
Srivastava et al. demonstrated positive expression and
allelic imbalance of TP53 and loss of heterozygosity
for D2S123 in glandular dysplastic foci but not in IM.
The authors therefore suggested that the presence of
dysplasia might be the early changes in the stepwise pro-
gression to adenocarcinoma [22]. Unfortunately, our data
could not provide sufficient evidence to answer this ques-
tion. More studies with patients with dysplasia are needed.
Implication for malignant potential of the IM might
also be obtained in the number of recurrences, which has
been estimated to be around 6 % in previous study [10].
Of 78 patients for whom follow-up was presented in our
study, 4 (5.0 %) were reported to have had recurrent le-
sions after a follow-up of 9 to 24 months. Although the
rates are lower than in transitional cell carcinoma, in three
cases the IM recurred two times. In fact, when cases of re-
currence are examined IM develops near the origin site in
many at the time of recurrence, and cases with a history
of chronic UTI before the development of IM are seen
frequently.
Our study has some methodologic factors that might
affect the accuracy of our estimates. First, it was a retro-
spective study of a limited number of patients. The pa-
tients were not followed up uniformly at regular intervals,
and the progression and recurrence may be higher if pa-
tients were followed more closely or regularly. Second, im-
munohistochemical staining was not routinely undertaken
during the study period. In contrast to other glandular le-
sions, IM commonly expresses staining for CDX2 and
CK20, which is often seen in colonic mucosa [23]. Third,
All lesions were surgical removed before the start of follow-
up. Hence, there was no residual lesion in the bladder and
all patients could be regarded to have normal urothelium at
the beginning of follow-up. Therefore, the nature history of
IM remains to be elucidated.
Conclusions
While intestinal metaplasia of the bladder are uncom-
mon, they are not rare in the male patients with chronic
urinary tract infection. The question of whether intes-
tinal metaplasia is a premalignant condition continues to
be a matter of debate. Although treatment such as trans-
urethral resection appears to be effective in most cases,
approximately 5 % of patients demonstrate postoperative
recurrence or progress to malignancy. Since the natural
history of intestinal metaplasia is unknown, close sur-
veillance following the surgery is necessary, particularly
in patients with dysplastic changes.
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